Evaluation of Triple-Negative Breast Cancer Early Detection via Mammography Screening and Outcomes in African American and White American Patients

Yalei Chen; Laura Susick; Melissa Davis; Jessica Bensenhaver; S David Nathanson; Jessica Burns; Lisa A Newman

doi:10.1001/jamasurg.2019.6032

Evaluation of Triple-Negative Breast Cancer Early Detection via Mammography Screening and Outcomes in African American and White American Patients

JAMA Surg. 2020 May 1;155(5):440-442. doi: 10.1001/jamasurg.2019.6032.

Authors

Yalei Chen¹, Laura Susick¹, Melissa Davis², Jessica Bensenhaver³, S David Nathanson³, Jessica Burns³, Lisa A Newman²

Affiliations

¹ Henry Ford Cancer Institute, Department of Public Health Sciences, Henry Ford Health System, Detroit, Michigan.
² Department of Surgery, Weill Cornell Medicine, New York, New York.
³ Henry Ford Cancer Institute, Department of Surgery, Henry Ford Health System, Detroit, Michigan.

Abstract

This cohort study examines triple-negative breast cancer detection via mammography screening, treatment, and survival rates in African American and white American women.

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Adult
Aged
Aged, 80 and over
Black or African American*
Early Detection of Cancer*
Female
Healthcare Disparities
Humans
Mammography*
Middle Aged
Retrospective Studies
Survival Rate
Triple Negative Breast Neoplasms / diagnostic imaging*
Triple Negative Breast Neoplasms / mortality
United States
White People*